Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE Guidance - January 2021

The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of January 2021. This month is one evidence summary that impacts upon primary care.

The Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections evidence summary has been published. The likely place in therapy for delafloxacin is as an option for adults needing hospital treatment for severe acute bacterial skin and skin structure infections (ABSSSI), primarily cellulitis or erysipelas, abscesses and wound infections, when standard oral and intravenous treatments are not suitable. Intravenous treatment may be switched to oral treatment after 3 days if possible. It would be expected that any necessary completion of treatment is provided on discharge.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - January 2021' on Email Share 'NICE Guidance - January 2021' on Delicious Share 'NICE Guidance - January 2021' on Digg Share 'NICE Guidance - January 2021' on Facebook Share 'NICE Guidance - January 2021' on reddit Share 'NICE Guidance - January 2021' on Twitter

atomic-wealth

No Comments to “NICE Guidance - January 2021”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

vipers